"Primaquine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
| Descriptor ID |
D011319
|
| MeSH Number(s) |
D03.633.100.810.050.650
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Primaquine".
Below are MeSH descriptors whose meaning is more specific than "Primaquine".
This graph shows the total number of publications written about "Primaquine" by people in this website by year, and whether "Primaquine" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 2 | 1 | 3 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 1 | 3 |
| 2012 | 1 | 2 | 3 |
| 2013 | 1 | 2 | 3 |
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 4 | 3 | 7 |
| 2017 | 2 | 0 | 2 |
| 2018 | 4 | 2 | 6 |
| 2019 | 4 | 1 | 5 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 2 | 3 | 5 |
| 2023 | 0 | 3 | 3 |
| 2024 | 2 | 0 | 2 |
| 2025 | 0 | 3 | 3 |
Below are the most recent publications written about "Primaquine" by people in Profiles.
-
FocaL mass drug administration for Plasmodium vivax malaria elimination (FLAME): study protocol for an open-label cluster randomized controlled trial in Peru. Trials. 2025 Oct 14; 26(1):408.
-
Acceptability and feasibility of glucose-6-phosphate dehydrogenase (G6PD) testing using SD Biosensor by village malaria workers in Cambodia: a qualitative study. BMJ Glob Health. 2025 Jun 16; 10(6).
-
Effect of mass drug administration on malaria incidence in southeast Senegal during 2020-22: a two-arm, open-label, cluster-randomised controlled trial. Lancet Infect Dis. 2025 Jun; 25(6):656-667.
-
Analysis of Severe and Relapse Risks of Imported Malaria in Five Provinces of China. Am J Trop Med Hyg. 2025 Mar 05; 112(3):593-600.
-
Effectiveness, Safety, and Acceptability of Primaquine Mass Drug Administration in Low-Endemicity Areas in Southern Thailand: Proof-of-Concept Study. JMIR Public Health Surveill. 2024 Jun 26; 10:e51993.
-
Population pharmacokinetics of primaquine and its metabolites in African males. Malar J. 2024 May 21; 23(1):159.
-
Factors hindering coverage of targeted mass treatment with primaquine in a malarious township of northern Myanmar in 2019-2020. Sci Rep. 2023 04 12; 13(1):5963.
-
Enhanced Ca2+-Dependent SK-Channel Gating and Membrane Trafficking in Human Atrial Fibrillation. Circ Res. 2023 04 28; 132(9):e116-e133.
-
Community acceptability, participation, and adherence to mass drug administration with primaquine for Plasmodium vivax elimination in Southern Thailand: a mixed methods approach. Malar J. 2023 Jan 13; 22(1):17.
-
Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data. BMC Med. 2022 09 16; 20(1):350.